A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
Clinical trial NCT03787953 · UNKNOWN
Trial details
- NCT number
- NCT03787953
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-12-30
- Primary completion
- 2019-09-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.